What is Ag-Biotech?
Established in 1997, Ag-Biotech operates as a specialized provider of genomic services and marker-assisted selection, serving as a critical partner for international crop development programs. The company offers a comprehensive suite of technical solutions, including PCR-based marker systems, DNA fingerprinting, and high-level biotechnology consulting. By focusing on the intersection of speed, transparency, and scientific rigor, Ag-Biotech enables breeders to optimize their cultivars with greater efficiency and cost-effectiveness. Their long-standing presence in the industry has solidified their reputation as a foundational entity for organizations seeking to integrate advanced molecular tools into traditional breeding workflows.
How much funding has Ag-Biotech raised?
Ag-Biotech has raised a total of $59K across 1 funding round:
Debt
$59K
Debt (2021): $59K with participation from PPP
Key Investors in Ag-Biotech
PPP
Public-Private Partnership
What's next for Ag-Biotech?
With the recent infusion of capital, Ag-Biotech is entering a critical phase of scaling its infrastructure to meet the rising demand for precision agriculture tools. The company is expected to prioritize the expansion of its genomic service capacity, potentially investing in automated laboratory technologies to further reduce turnaround times for global clients. As the agricultural sector continues to prioritize climate-resilient and high-yield crop development, Ag-Biotech's strategic focus will likely shift toward deepening its consulting reach and refining its proprietary marker systems. This growth trajectory suggests a move toward broader market penetration, ensuring that their molecular breeding expertise remains at the forefront of the global food security supply chain.
See full Ag-Biotech company page
